High-grade serous tubo-ovarian carcinoma presenting as paraneoplastic cerebellar degeneration

被引:0
|
作者
Butt, E. [1 ]
Chadda, K. R. [1 ,2 ]
Tadross, J. A. [3 ]
Latimer, J. [4 ]
机构
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge, England
[2] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England
[3] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Metab Dis Unit,Metab Res Labs,Wellcome Trust, Cambridge, England
[4] Addenbrookes Hosp, Div Gynaecol Oncol, Dept Gynaecol, Cambridge, England
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
1362
引用
收藏
页码:95 / 95
页数:1
相关论文
共 50 条
  • [1] Rare case of paraneoplastic cerebellar degeneration secondary to high-grade serous carcinoma of tubo-ovarian origin
    Butt, Eman
    Tadross, John A.
    Chadda, Karan R.
    Latimer, John
    BMJ CASE REPORTS, 2019, 12 (08)
  • [2] High-grade serous carcinoma of tubo-ovarian origin: recent developments
    Singh, Naveena
    McCluggage, W. Glenn
    Gilks, C. Blake
    HISTOPATHOLOGY, 2017, 71 (03) : 339 - 356
  • [3] Morphological patterns of high-grade serous tubo-ovarian carcinoma in association with HRD
    Aquino Correa, M. E.
    Valdivieso, L.
    Castillo, A.
    Jimeno, M.
    Hernandez, L.
    Garcia-Gomez, J.
    Matute-Molina, K.
    Feu, A.
    VIRCHOWS ARCHIV, 2024, 485 : S82 - S83
  • [4] Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma
    Santandrea, Giacomo
    Ceccarelli, Claudio
    Santini, Donatella
    Turchetti, Daniela
    Zamagni, Claudio
    Perrone, Anna Myriam
    De Iaco, Pierandrea
    De Leo, Antonio
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 744 - 744
  • [5] Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma
    Santandrea, Giacomo
    Ceccarelli, Claudio
    Santini, Donatella
    Turchetti, Daniela
    Zamagni, Claudio
    Perrone, Anna Myriam
    De Iaco, Pierandrea
    De Leo, Antonio
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 744 - 744
  • [6] Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters
    Westbom-Fremer, Sofia
    Tran, Lena
    Ebbesson, Anna
    de la Fuente, Laura Martin
    Jonsson, Jenny-Maria
    Kannisto, Paivi
    Veerla, Srinivas
    Hedenfalk, Ingrid
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (02)
  • [7] The Clinicopathological and Prognostic Values of Chemotherapy Response Score in Tubo-Ovarian High-Grade Serous Carcinoma
    Derogar, Roghaiyeh
    Mirzaei, Amirreza
    Sayyah-Melli, Manizheh
    Jafari-Shobeiri, Mehri
    Rahmani, Vahideh
    Vaezi, Maryam
    Dastranj Tabrizi, Ali
    Mostafa-Gharabaghi, Parvin
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (02)
  • [8] SPL-108 mediates metastasis and chemoresistance in high-grade serous tubo-ovarian carcinoma
    Lara, Olivia
    Pereira, Luiza Doro
    Van Oudenhove, Elke
    Olvera, Narciso
    Dao, Fanny
    Hacker, Kari
    Levine, Douglas
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S276 - S276
  • [9] LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma
    Kolb, Svenja
    Hoffmann, Inga
    Monje, Nanna
    Dragomir, Mihnea P.
    Jank, Paul
    Bischoff, Philip
    Keunecke, Carlotta
    Pohl, Jonathan
    Kunze, Catarina Alisa
    Marchenko, Sofya
    Schmitt, Wolfgang D.
    Kulbe, Hagen
    Sers, Christine
    Sehouli, Jalid
    Braicu, Elena Ioana
    Denkert, Carsten
    Darb-Esfahani, Silvia
    Horst, David
    Sinn, Bruno V.
    Taube, Eliane T.
    HUMAN PATHOLOGY, 2023, 141 : 158 - 168
  • [10] Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma
    Bohm, Steffen
    Montfort, Anne
    Pearce, Oliver M. T.
    Topping, Joanne
    Chakravarty, Probir
    Everitt, Gemma L. A.
    Clear, Andrew
    McDermott, Jackie R.
    Ennis, Darren
    Dowe, Thomas
    Fitzpatrick, Amanda
    Brockbank, Elly C.
    Lawrence, Alexandra C.
    Jeyarajah, Arjun
    Faruqi, Asma Z.
    McNeish, Iain A.
    Singh, Naveena
    Lockley, Michelle
    Balkwill, Frances R.
    CLINICAL CANCER RESEARCH, 2016, 22 (12) : 3025 - 3036